PTC Therapeutics (PTCT) Earnings Date, Estimates & Call Transcripts $45.52 -0.69 (-1.49%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$44.74 -0.78 (-1.71%) As of 06:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PTC Therapeutics Earnings Summary PTC Therapeutics issued Q1 2025 earnings on May 6, 2025, reporting an EPS of $10.04, which beat the consensus estimate of $0.85 by $9.19. Quarterly revenue fell 9.6% year-over-year to $1.18 billion, above analysts' expectations of $437.16 million. With a trailing EPS of $6.51, PTC Therapeutics' earnings are expected to decrease next year, from ($4.52) to ($4.69) per share. Latest Q1 Earnings DateMay. 6EstimatedConsensus EPS (May. 6) $0.85 Actual EPS (May. 6) $10.04 Beat By $9.19 Actual Revenue (May. 6) $1.18BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get PTC Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PTC Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPTCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PTCT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. PTC Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$10.04$10.04$10.04Q2 20252-$1.00-$0.96-$0.98Q3 20252-$1.36-$1.04-$1.20Q4 20252-$1.22-$1.04-$1.13 FY 2025 8 $6.46 $7.00 $6.73 Q1 20261-$0.85-$0.85-$0.85Q2 20261-$0.78-$0.78-$0.78Q3 20261-$0.69-$0.69-$0.69Q4 20261-$0.48-$0.48-$0.48 PTC Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/6/2025-$0.85$10.04+$9.19-$437.16M$1.18B11/7/2024Q3 2024-$1.54-$1.39+$0.15-$1.39$173.51M$196.79M8/8/2024Q2 2024-$1.00-$1.16 -$0.16-$1.03$192.12M$186.70M4/25/2024Q1 2024-$1.21-$1.20+$0.01-$1.20$160.27M$210.12M2/29/2024Q4 2023$0.29-$0.24 -$0.53$1.58$315.90M$307.06M10/26/2023Q3 2023-$0.85-$1.76 -$0.91-$1.76$210.23M$196.60M8/3/2023Q2 2023-$1.58-$2.66 -$1.08-$2.66$206.99M$213.80M PTC Therapeutics Earnings - Frequently Asked Questions When did PTC Therapeutics announce their last quarterly earnings? PTC Therapeutics (NASDAQ:PTCT) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on PTCT's earnings history. What guidance has PTC Therapeutics issued on next quarter's earnings? PTC Therapeutics issued an update on its FY 2025 earnings guidance on Tuesday, May, 6th. The company issued revenue guidance of $650.0 million-$800.0 million, compared to the consensus revenue estimate of $872.2 million. Did PTC Therapeutics beat their earnings estimates last quarter? In the previous quarter, PTC Therapeutics (NASDAQ:PTCT) reported $10.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.85 by $9.19. Learn more on analysts' earnings estimate vs. PTCT's actual earnings. How can I listen to PTC Therapeutics's earnings conference call? The conference call for PTC Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read PTC Therapeutics's conference call transcript? The conference call transcript for PTC Therapeutics's latest earnings report can be read online. Read Transcript How can I view PTC Therapeutics's earnings report? PTC Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded annual revenue of $1.77 billion. How much profit does PTC Therapeutics generate each year? PTC Therapeutics (NASDAQ:PTCT) has a recorded net income of -$626.60 million. PTCT has generated $6.51 earnings per share over the last four quarters. What is PTC Therapeutics's EPS forecast for next year? PTC Therapeutics's earnings are expected to decrease from ($4.52) per share to ($4.69) per share in the next year. More Earnings Resources from MarketBeat Related Companies ITCI Earnings Results GMAB Earnings Results RDY Earnings Results VTRS Earnings Results MRNA Earnings Results ASND Earnings Results QGEN Earnings Results ROIV Earnings Results RVMD Earnings Results ELAN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:PTCT) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PTC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
